ASMANEX TWISTHALER 400 MCG — DIN 02243596
MOMETASONE FUROATE : 400 MCG · ORGANON CANADA INC. · POWDER · wholesale supply in Canada
Health Canada status: MARKETED
What is ASMANEX TWISTHALER?
ASMANEX TWISTHALER 400 MCG contains MOMETASONE FUROATE : 400 MCG. It is listed in the Health Canada Drug Product Database under DIN 02243596, held by ORGANON CANADA INC., supplied as POWDER for INHALATION administration. Health Canada currently lists it as marketed, status dated 04-Jan-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ASMANEX TWISTHALER used for?
Prophylactic management of steroid-responsive bronchial asthma in patients 4 years of age and older. Not for acute treatment.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Mometasone cost around the world?
Mometasone is listed on 8 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Greece publishes a producer price (ex-factory); Hungary publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Australia | ex-manufacturer | 6 | 59 | AUD███.██ |
| Greece | producer price (ex-factory) | 16 | 16 | EUR███.██ |
| Italy | prezzo al pubblico (classe A) | 7 | 7 | EUR███.██ |
| United Kingdom | hospital | 5 | 5 | GBP███.██ |
| Hungary | producer price (ex-factory) | 4 | 4 | HUF███.██ |
| Morocco | PPV (public price) | 2 | 3 | MAD███.██ |
| South Africa | single exit price | 2 | 2 | ZAR███.██ |
| United Arab Emirates | public | 1 | 1 | AED███.██ |
97 pack listings across 43 brand entries and 7 price bases, refreshed 08 Sep 2026. Ranges span every Mometasone pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Mometasone in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
Only one market authorization holder has a Canadian DIN containing Mometasone — 3 DINs, of which 3 are currently marketed. There is no second Canadian source today, so a supply interruption on this holder has no domestic substitute at the same molecule.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ORGANON CANADA INC. | 3 | 3 | ASMANEX TWISTHALER | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 400 MCG |
|---|---|
| Dosage form | POWDER |
| Route | INHALATION |
| Pack configuration (monograph) | Multi-dose dry powder inhaler (30 or 60 metered doses) supplied in a protective foil pouch. Available in 100 mcg (grey), 200 mcg (pink), and 400 mcg (maroon) strengths. |
| Storage | Not explicitly detailed in provided text snippet (Section 11 header present but content truncated), though typically store in a dry place. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Mometasone |
|---|---|
| ATC code | R03BA07 |
| AHFS class | 68:04.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02243596 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2243596 |
| Brand name | ASMANEX TWISTHALER |
| Generic / active ingredient | MOMETASONE FUROATE : 400 MCG |
| Market authorization holder | ORGANON CANADA INC. |
| Health Canada schedule | Prescription |
| ATC code | R03BA07 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R03BA |
| Current status | MARKETED |
| Status date | 04-Jan-2022 |
| Original market date | 2011-12-21 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Oral inhalation only. Adults/Adolescents (12+): 200-400 mcg once daily (evening) or 200-400 mcg twice daily. Pediatrics (4-11): 100 mcg once daily (evening). Rinse mouth after use.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to mometasone furoate, milk proteins (lactose), or any ingredient. Primary treatment of status asthmaticus. Untreated systemic infections (fungal, bacterial, viral, parasitic).
Warnings and precautions
Not for acute attacks. Risk of HPA axis suppression, adrenal insufficiency (especially when transferring from oral steroids), immunosuppression, and reduced bone mineral density.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
3 of 3 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ASMANEX TWISTHALER | 200 MCG | POWDER | ORGANON CANADA INC. | MARKETED | 02243595 |
| ASMANEX TWISTHALER | 100 MCG | POWDER | ORGANON CANADA INC. | MARKETED | 02438690 |
2 · Same class — other molecules in ATC R03BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Fluticasone | AERMONY RESPICLICK · APO-FLUTICASONE HFA · FLOVENT DISKUS · FLOVENT HFA · +10 more | 27 | 12 | Yes |
| Budesonide | PULMICORT NEBUAMP 0.125 MG/ML · PULMICORT NEBUAMP 0.25 MG/ML · PULMICORT NEBUAMP 0.5 MG/ML · PULMICORT TURBUHALER · +2 more | 12 | 12 | Yes |
| Mometasone | ASMANEX TWISTHALER | 3 | 3 | Yes |
| Beclometasone | ALTI-BECLOMETHASONE DIPROPIONATE INHALER 50MCG/MD · BECLODISK - PWR INH 100MCG/BLISTER · BECLODISK - PWR INH 200MCG/BLISTER · BECLODISK PWR 100MCG/BLISTER · +12 more | 17 | 2 | Yes |
| Ciclesonide | ALVESCO | 3 | 2 | Yes |
| Fluticasone Furoate | ARNUITY ELLIPTA | 2 | 2 | Yes |
| Flunisolide | BRONALIDE INHAL 250MCG/AEM | 1 | 0 | Not in Canada |
| Triamcinolone | AZMACORT | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R03B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R03BB | Aclidinium Bromide · Glycopyrronium Bromide · Ipratropium Bromide · Tiotropium Bromide · Umeclidinium Bromide | 37 | 15 |
| R03BC | Cromoglicic Acid · Nedocromil | 11 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is ASMANEX TWISTHALER called?
The same molecule, Mometasone, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Novasone | Latin | Australia |
| Elocon | Latin | Australia |
| Zatamil | Latin | Australia |
| Elocon Alcohol Free | Latin | Australia |
| GLENMARK MOMETASONE | Latin | Australia |
| GLENMARK MOMETASONE Alcohol Free | Latin | Australia |
| NASONEX | Latin | Morocco |
| Aspen Mometasone Cream | Latin | South Africa |
| Rhinimet | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.